Bristol-Myers Squibb buy Guggenheim
Start price
06.02.26
/
50%
€50.43
Target price
06.02.27
-
Performance (%)
-0.65%
Price
18:30
€50.10
Summary
This prediction is currently active. Since the start of the prediction for Bristol-Myers Squibb the price has only changed by -0.65%. This prediction currently runs until 06.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -5.231% | -5.231% |
| iShares Core DAX® | 0.231% | -2.413% |
| iShares Nasdaq 100 | 1.663% | -1.658% |
| iShares Nikkei 225® | -0.208% | -2.502% |
| iShares S&P 500 | 1.067% | -1.579% |
Comments by Guggenheim for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for BMY provided by MarketBeat